Cervical Carcinosarcoma: Current Understanding on Pathogenesis, Diagnosis, Management and Future Perspectives

Area of Science:

• Gynecologic Oncology
• Pathology
• Oncologic Surgery

Background:

• Cervical carcinosarcoma (CCS) is a rare, aggressive malignancy, accounting for less than 1% of cervical cancers.
• The metaplastic (monoclonal) theory is the widely accepted theory for CCS pathogenesis.
• CCS is often misdiagnosed as uterine carcinosarcoma or common cervical cancer due to similar symptoms like abnormal vaginal bleeding.

Purpose of the Study:

• To review and synthesize existing literature on cervical carcinosarcoma (CCS).
• To provide comprehensive information on CCS epidemiology, clinical presentations, pathogenesis, diagnosis, and treatment.
• To assist clinicians in diagnosing and managing CCS effectively.

Main Methods:

• Comprehensive literature search and review.
• Synthesis of data regarding epidemiology, clinical features, and etiology.
• Compilation of current diagnostic and therapeutic strategies.

Main Results:

• CCS is less common than uterine corpus counterparts and often diagnosed earlier.
• Management strategies are frequently extrapolated from uterine carcinosarcoma or other cervical cancers.
• There is a lack of consensus regarding CCS survival, management, and prognostic factors.

Conclusions:

• Further research is needed to establish consensus on CCS management and prognosis.
• Understanding CCS's unique characteristics is crucial for accurate diagnosis and effective treatment.
• This review provides a foundational resource for clinicians managing cervical carcinosarcoma.